AC Immune SA gets Lilly milestone for Alzheimers’ candidate
AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2185 entries already.
Entries by Thomas Gabrielczyk
Experts discuss link between sepsis and Covid-19
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries AG establishes production of recombinant collagen
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
BioNTech SE’s COVID-19 vaccine attracts investment
Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTech’d mRNA vaccine BNT162.
Commission relaunches circular economy action plan
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Roche unravel biomarker for checkpoint blockade
Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
CRO opens new branch office in Berlin
FGK Clinical Research GmbH opens a branch office in Berlin this month. The Berlin office will support the operative units at the German headquarters in Munich.
Nutrition influences the course of MS
New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).
LSP launches US-$600m European life sciences fund
LSP has closed its LSP 6 fund at the $600m hard cap. It is the largest fund ever raised in Europe focused on life sciences ventures.
Biotalys grabs €45m in Series C financing
Pest control specialist Biotalys NV has raised an additional €10m to its series C financing bringing its amount to €45m.